Literature DB >> 4160788

Fluorescein studies in fundus flavimaculatus and drusen.

J T Ernest, A E Krill.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 4160788     DOI: 10.1016/0002-9394(66)91668-0

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


× No keyword cloud information.
  17 in total

1.  Color vision in Stargardt's disease.

Authors:  M Mäntyjärvi; K Tuppurainen
Journal:  Int Ophthalmol       Date:  1992-11       Impact factor: 2.031

2.  The various categories of juvenile macular degeneration.

Authors:  A E Krill; A F Deutman
Journal:  Trans Am Ophthalmol Soc       Date:  1972

3.  Drusen of the disc and retinal haemorrhages.

Authors:  J D Brodrick
Journal:  Br J Ophthalmol       Date:  1973-05       Impact factor: 4.638

4.  Dominantly inherited drusen of Bruch's membrane.

Authors:  A F Deutman; L M Jansen
Journal:  Br J Ophthalmol       Date:  1970-06       Impact factor: 4.638

5.  Fluorescein fundus photography of angioid streaks.

Authors:  B Patnaik; S R Malik
Journal:  Br J Ophthalmol       Date:  1971-12       Impact factor: 4.638

6.  Fluorescein studies in diseases affecting the pigment epithelium.

Authors:  A E Krill; F W Newell; M I Chishti
Journal:  Trans Am Ophthalmol Soc       Date:  1968

7.  Stargardt's disease and fundus flavimaculatus: evaluation of morphologic progression and intrafamilial co-existence.

Authors:  T M Aaberg
Journal:  Trans Am Ophthalmol Soc       Date:  1986

Review 8.  Clinical spectrum, genetic complexity and therapeutic approaches for retinal disease caused by ABCA4 mutations.

Authors:  Frans P M Cremers; Winston Lee; Rob W J Collin; Rando Allikmets
Journal:  Prog Retin Eye Res       Date:  2020-04-09       Impact factor: 21.198

9.  Benign familial fleck retina.

Authors:  S F Sabel Aish; B Dajani
Journal:  Br J Ophthalmol       Date:  1980-09       Impact factor: 4.638

10.  A clinical review of Stargardt's disease and/or fundus flavimaculatus with follow-up.

Authors:  O Gelisken; J J De Laey
Journal:  Int Ophthalmol       Date:  1985-11       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.